NovaBay Pharma (NBY) Tops Q4 EPS by 3c

Go back to NovaBay Pharma (NBY) Tops Q4 EPS by 3c

NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results

March 29, 2022 4:05 PM EDT

Fourth quarter net product revenue increased 40% on record Avenova spray unit sales 2021 Avenova spray net revenue increased 15% on 31% growth in unit sales 2020 net product revenue boosted by $3.1 million in non-recurring PPE product sales Company executing on growth strategy with DERMAdoctor acquisition

Conference call begins at 4:30 p.m. Eastern time today

EMERYVILLE, Calif.--(BUSINESS... More